Lupus Research Group

The Brunner research group focuses on biomarker discovery, the testing of new medications for lupus and trial design. The lab is working on many projects related to lupus, including:

  • Finding better ways to measure and monitor kidney inflammation and damage
  • Exploring changes in the brain tissues of children with lupus that lead to neuropsychiatric lupus symptoms using advanced imaging techniques
  • Developing computer-based screening tests to identify children with neuropsychiatric lupus symptoms early
  • Development of outcome measures to be used in clinical trials of lupus
  • Performance of clinical trials of new lupus medications
  • Discovering new drugs for lupus
  • Studying the benefits of precision medicine when used for children with lupus nephritis

Hermine Brunner, Chief of Rheumatology and Director of the Lupus Center at Cincinnati Children’s, is a pediatric rheumatologist with a special clinical and research interest in pediatric lupus. She pioneers the development of outcome measures, biomarkers, and improving the quality of care for children with lupus and other rheumatic diseases. Brunner serves as the scientific director of the Pediatric Rheumatology Collaborative Study Group.